Published in J Clin Densitom on January 01, 2005
Low bone mineral density and fracture burden in postmenopausal women. CMAJ (2007) 1.81
Influence of recency and duration of glucocorticoid use on bone mineral density and risk of fractures: population-based cohort study. Osteoporos Int (2013) 1.46
A population-based analysis of the post-fracture care gap 1996-2008: the situation is not improving. Osteoporos Int (2011) 1.34
Construction and validation of a simplified fracture risk assessment tool for Canadian women and men: results from the CaMos and Manitoba cohorts. Osteoporos Int (2010) 1.27
Construction of a FRAX® model for the assessment of fracture probability in Canada and implications for treatment. Osteoporos Int (2010) 1.25
Spine-hip discordance and fracture risk assessment: a physician-friendly FRAX enhancement. Osteoporos Int (2010) 1.18
Weight and body mass index predict bone mineral density and fractures in women aged 40 to 59 years. Osteoporos Int (2008) 1.15
Fracture risk assessment without bone density measurement in routine clinical practice. Osteoporos Int (2011) 1.08
Trabecular bone score (TBS) as a new complementary approach for osteoporosis evaluation in clinical practice. Bone (2015) 1.08
Prediction of hip and other osteoporotic fractures from hip geometry in a large clinical cohort. Osteoporos Int (2009) 1.03
Closing the gap in postfracture care at the population level: a randomized controlled trial. CMAJ (2011) 1.00
Competing mortality and fracture risk assessment. Osteoporos Int (2012) 0.99
Lumbar spine texture enhances 10-year fracture probability assessment. Osteoporos Int (2014) 0.95
High fracture probability with FRAX usually indicates densitometric osteoporosis: implications for clinical practice. Osteoporos Int (2011) 0.92
The effect of socioeconomic status on bone density testing in a public health-care system. Osteoporos Int (2006) 0.90
High bone mineral density is associated with high body mass index. Osteoporos Int (2008) 0.89
Does diabetes modify the effect of FRAX risk factors for predicting major osteoporotic and hip fracture? Osteoporos Int (2014) 0.88
Validation of a case definition for osteoporosis disease surveillance. Osteoporos Int (2010) 0.88
Validation of the Provincial Transfer Authorization Centre database: a comprehensive database containing records of all inter-facility patient transfers in the province of Ontario. BMC Health Serv Res (2006) 0.87
Effects of anti-resorptive agents on trabecular bone score (TBS) in older women. Osteoporos Int (2012) 0.86
Prediction of Incident Major Osteoporotic and Hip Fractures by Trabecular Bone Score (TBS) and Prevalent Radiographic Vertebral Fracture in Older Men. J Bone Miner Res (2015) 0.86
Factors predicting osteoporosis treatment initiation in a regionally based cohort. Osteoporos Int (2008) 0.85
Positive celiac disease serology and reduced bone mineral density in adult women. Can J Gastroenterol (2010) 0.82
Minimum sample size requirements for bone density precision assessment produce inconsistency in clinical monitoring. Osteoporos Int (2006) 0.80
A comparative study of using non-hip bone density inputs with FRAX®. Osteoporos Int (2011) 0.79
The impact of hip subregion reference data on osteoporosis diagnosis. Osteoporos Int (2005) 0.78
Associations between adverse social position and bone mineral density in women aged 50 years or older: data from the Manitoba Bone Density Program. Osteoporos Int (2013) 0.77
Associations of Body Mass Index With Incident Fractures and Hip Structural Parameters in a Large Canadian Cohort. J Clin Endocrinol Metab (2015) 0.77
Longer Duration of Diabetes Strongly Impacts Fracture Risk Assessment: The Manitoba BMD Cohort. J Clin Endocrinol Metab (2016) 0.75
Clinical risk factors for fracture in diabetes: a matched cohort analysis. J Clin Densitom (2011) 0.75
Optimal decision criterion for detecting change in bone mineral density during serial monitoring: a Bayesian approach. Osteoporos Int (2008) 0.75
FRAX for fracture prediction shorter and longer than 10 years: the Manitoba BMD registry. Osteoporos Int (2017) 0.75
Clinical performance of an updated trabecular bone score (TBS) algorithm in men and women: the Manitoba BMD cohort. Osteoporos Int (2017) 0.75
Association of Mental Disorders and Related Medication Use With Risk for Major Osteoporotic Fractures. JAMA Psychiatry (2017) 0.75
Direct comparison of FRAX(R) and a simplified fracture risk assessment tool in routine clinical practice: a registry-based cohort study. Osteoporos Int (2016) 0.75
Fracture prediction from repeat BMD measurements in clinical practice. Osteoporos Int (2015) 0.75
Income-Based Drug Coverage in British Columbia: Lessons for BC and the Rest of Canada. Healthc Policy (2006) 1.73
Effectiveness of bone density measurement for predicting osteoporotic fractures in clinical practice. J Clin Endocrinol Metab (2006) 1.39
The effect of neighborhood socioeconomic status on education and health outcomes for children living in social housing. Am J Public Health (2014) 1.29
"Breakthrough" drugs and growth in expenditure on prescription drugs in Canada. BMJ (2005) 1.24
Antidepressant utilization in British Columbia from 1996 to 2004: increasing prevalence but not incidence. Psychiatr Serv (2007) 1.05
Single-site vs multisite bone density measurement for fracture prediction. Arch Intern Med (2007) 1.02
Closing the gap in postfracture care at the population level: a randomized controlled trial. CMAJ (2011) 1.00
Direct costs of fractures in Canada and trends 1996-2006: a population-based cost-of-illness analysis. J Bone Miner Res (2011) 0.95
Number of osteoporotic sites and fracture risk assessment: a cohort study from the Manitoba Bone Density Program. J Bone Miner Res (2007) 0.94
A population-based study of osteoporosis testing and treatment following introduction of a new bone densitometry service. Osteoporos Int (2004) 0.90
A methodology for estimating hospital bed need in Manitoba in 2020. Can J Aging (2005) 0.87
Use of health, education, and social services by individuals with fetal alcohol spectrum disorder. J Popul Ther Clin Pharmacol (2013) 0.79
The impact of hip subregion reference data on osteoporosis diagnosis. Osteoporos Int (2005) 0.78
Martens et al. respond. Am J Public Health (2015) 0.75